Landiolol - CAS 133242-30-5
Catalog number: 133242-30-5
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C25H39N3O8
Molecular Weight:
509.60
COA:
Inquire
Targets:
Adrenergic Receptor
Description:
Landiolol is an ultra-short-acting Beta 1 adrenergic receptor antagonist using for managing supraventricular tachyarrhythmias in sepsis. It is also used as an anti-arrhythmic agent.
Publictions citing BOC Sciences Products
  • >> More
Purity:
> 95%
Appearance:
Powder
Synonyms:
Ono 1101; UNII-62NWQ924LH; [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl 3-[4-[(2S)-2-hydroxy-3-[2-(morpholine-4-carbonylamino)ethylamino]propoxy]phenyl]propanoate;144481-98-1(hydrochloride)
Solubility:
Soluble in DMSO
Storage:
-20°C Freezer
MSDS:
Inquire
Application:
antiarrhythmic agent
Quality Standard:
In-house standard
Shelf Life:
2 month in rt, long time
Quantity:
Milligrams-Grams
InChIKey:
WMDSZGFJQKSLLH-RBBKRZOGSA-N
InChI:
1S/C25H39N3O8/c1-25(2)35-18-22(36-25)17-34-23(30)8-5-19-3-6-21(7-4-19)33-16-20(29)15-26-9-10-27-24(31)28-11-13-32-14-12-28/h3-4,6-7,20,22,26,29H,5,8-18H2,1-2H3,(H,27,31)/t20-,22+/m0/s1
Canonical SMILES:
C1(OC[C@H](O1)COC(CCc1ccc(OC[C@H](CNCCNC(N2CCOCC2)=O)O)cc1)=O)(C)C
Current Developer:
Originator Ono Pharmaceutical
1.[A Case of Undiagnosed Extra-adrenal Pheochromocytoma in an Adult Patient with Single Ventricle Circulation after the Bidirectional Glenn Operation].
Kohno M, Nagamine Y, Goto T. Masui. 2015 Sep;64(9):985-8.
We experienced a case of undiagnosed extra-adrenal pheochromocytoma in an adult patient with single ventricle circulation after the bidirectional Glenn operation. A 32-year-old woman was scheduled for open abdominal surgery for incidental retroperitoneal tumor. She had undergone the bidirectional Glenn operation for complex congenital heart disease consisting of double outlet right ventricle, ventricular septal defect, and pulmonary artery stenosis. She had not undergone the Fontan operation because of insufficient development of pulmonary circulation. Her physical status was New York Heart Association (NYHA) functional class II, and her oxygen saturation was 80% in room air. She reported no symptoms for the abdominal tumor preoperatively. The surgery was performed under general and epidural anesthesia. After induction of general anesthesia, she developed hypertension and tachycardia, and the manipulation of the tumor worsened them. Landiolol, a short acting beta blocker, and nicardipine were administrated.
2.[Usefullness of Beta-blocker for Hemodynamic Changes Induced by Uterotonic Drug in a Patient with Hypertrophic Obstructive Cardiomyopathy Undergoing Elective Cesarean Section].
Tsukano Y, Sugita M, Ikuta Y, Yamamoto T. Masui. 2015 Jun;64(6):642-6.
Combined spinal-epidural anesthesia (CSEA) was given to a 27-year-old woman with hypertrophic obstructive cardiomyopathy (HOCM) for a selective cesarean section. After the injection of uterotonic drug via uterine muscle and a vein after delivery, the patient developed dyspnea, tachycardia, ST-change on elecrocardiogram and hypotension. It is important in HOCM patients to control heart rate and left ventricular contractile force. We started to infuse beta-blocker (landiolol, 10 μg x kg(-1) x min(-1)) and improved these symptoms of the patient. This case demonstrates that CSEA is safe for HOCM patients and beta-blocker is effective to improve hemodynamic changes induced by uterotonic drug in these patients.
3.Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients.
Shibata SC1, Uchiyama A2, Ohta N2, Fujino Y2. J Cardiothorac Vasc Anesth. 2016 Apr;30(2):418-22. doi: 10.1053/j.jvca.2015.09.007. Epub 2015 Sep 25.
OBJECTIVE: The authors assessed the efficacy and safety of landiolol, an ultra-short-acting beta-blocker, with those of amiodarone in the restoration of sinus rhythm for postoperative atrial fibrillation (POAF) in intensive care unit (ICU) patients.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Adrenergic Receptor Products


CAS 18910-65-1 Salmefamol

Salmefamol
(CAS: 18910-65-1)

Salmefamol is a beta2-adrenoceptor agonist which is useful for treatment of respiratory diseases.

CAS 226081-74-9 AR-​08

AR-​08
(CAS: 226081-74-9)

AR-​08 is an agonist of α2-adrenergic receptor undergone in phase II clinical trials by Arbor Pharmaceuticals for the treatment of attention deficit and hyperac...

Aptazapine maleate
(CAS: 71576-41-5)

Aptazapine is a tetracyclic antidepressant. It was assayed in clinical trials for the treatment of depression in the 1980s but was never marketed. Aptazapine is...

Abanoquil mesilate
(CAS: 118931-00-3)

This molecular is an active biochemical as a Alpha 1 adrenergic receptor antagonist. However, no developments were reported for Ischaemic heart disorders and A...

CAS 77883-43-3 Doxazosin Mesylate

Doxazosin Mesylate
(CAS: 77883-43-3)

Doxazosin mesylate is an α1-selective alpha blocker used to treat high blood pressure and urinary retention associated with benign prostatic hyperplasia.

CAS 133163-28-7 Midodrine

Midodrine
(CAS: 133163-28-7)

Midodrine is a Alpha adrenergic receptor under the development of Shire for the treatment of dysautonomia and orthostatic hypotension. In August 2010, the FDA p...

CAS 7361-61-7 Xylazine

Xylazine
(CAS: 7361-61-7)

Xylazine is an analogue of clonidine, which is an agonist at the α2 class of adrenergic receptor. It is a drug used for sedation, anesthesia, muscle relaxation ...

CAS 147568-66-9 Carmoterol

Carmoterol
(CAS: 147568-66-9)

Carmoterol, a quinolin derivative, has been found to a β2-adrenoceptor agonist that could be an effective bronchodilating agent.

CAS 23256-50-0 Guanabenz Acetate

Guanabenz Acetate
(CAS: 23256-50-0)

Guanabenz Acetate is an selective agonist of α2a-adrenergic receptor, α2b-adrenergic receptor and α2c-adrenergic receptor with pEC50 of 8.25, 7.01 and ~5, respe...

CAS 6452-71-7 Oxprenolol

Oxprenolol
(CAS: 6452-71-7)

Oxprenolol is a lipophilic, non-selective beta-adrenergic blocker. It has some intrinsic sympathomimetic activity and is used for the treatment of angina pector...

CAS 149247-12-1 QF0301B

QF0301B
(CAS: 149247-12-1)

QF0301B is an α1 adrenergic receptor antagonist and shows noncompetitive low action in 5-HT3, muscarinic and nicotinic receptors, or as Ca2+ antagonist.

CAS 128470-16-6 Arbutamine

Arbutamine
(CAS: 128470-16-6)

Arbutamine is β-adrenergic receptor originated by SICOR. It is a cardiac stimulant. Arbutamine is a synthetic catecholamine with positive chronotropic and inotr...

CAS 148849-67-6 Ivabradine HCl

Ivabradine HCl
(CAS: 148849-67-6)

Ivabradine HCl, a new If inhibitor with IC 50 of 2.9 μM which acts specifically on the pacemaker activity of the sinoatrial node, is a pure heart rate lowering ...

CAS 36085-44-6 B-HT 958 dihydrochloride

B-HT 958 dihydrochloride
(CAS: 36085-44-6)

B-HT 958 dihydrochloride is a dopamine D2 receptor agonist and an α2-adrenoceptor partial agonist.

CAS 829-74-3 Levonordefrin

Levonordefrin
(CAS: 829-74-3)

Levonordefrin is a adrenergic receptor agonist and can be used as a topical nasal decongestant and vasoconstrictor in dentistry in the United States. Levonordef...

CAS 86880-51-5 ICI141292

ICI141292
(CAS: 86880-51-5)

ICI141292, also known as Epanolol, is a adrenergic β-antagonist with a greater affinity for β1- than β2-adrenoceptors, which is used for treatment of hypertensi...

CAS 41372-08-1 L-α-Methyl DOPA Hydrate

L-α-Methyl DOPA Hydrate
(CAS: 41372-08-1)

L-α-Methyl DOPA Hydrate is an alpha-adrenergic agonist used as a sympatholytic or antihypertensive.

CAS 43229-80-7 Formoterol Hemifumarate

Formoterol Hemifumarate
(CAS: 43229-80-7)

Formoterol Hemifumarate is a potent, selective and long-acting β2-adrenoceptor agonist to β2 and β1 receptors with pKd of 8.12 and 5.58, respectively.

CAS 56-47-3 Deoxycorticosterone acetate

Deoxycorticosterone acetate
(CAS: 56-47-3)

Deoxycorticosterone acetate is a steroid hormone used for intramuscular injection for replacement therapy of the adrenocortical steroid.

Batefenterol
(CAS: 743461-65-6)

Batefenterol is a Beta 2 adrenergic receptor agonist and also a Muscarinic receptor antagonist. It shows high affinity for hM2 (Ki = 1.4 nM), hM3 muscarinic rec...

Chemical Structure

CAS 133242-30-5 Landiolol

Quick Inquiry

Verification code

Featured Items